Geode Capital Management, LLC Acelrx Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.2 - $0.35 $16,894 - $29,565
84,473 Added 7.84%
1,162,072 $242,000
Q2 2022

Aug 12, 2022
BUY
$0.18 - $0.29 $1,706 - $2,749
9,481 Added 0.89%
1,077,599 $263,000
Q1 2022

May 13, 2022
BUY
$0.28 - $0.61 $24,501 - $53,378
87,506 Added 8.92%
1,068,118 $304,000
Q4 2021

Feb 11, 2022
SELL
$0.49 - $1.02 $2,274 - $4,733
-4,641 Reduced 0.47%
980,612 $549,000
Q3 2021

Nov 12, 2021
SELL
$0.93 - $1.51 $60,964 - $98,985
-65,553 Reduced 6.24%
985,253 $1 Million
Q2 2021

Aug 13, 2021
SELL
$1.03 - $1.7 $639,374 - $1.06 Million
-620,752 Reduced 37.14%
1,050,806 $1.45 Million
Q1 2021

May 12, 2021
BUY
$1.25 - $2.77 $557,342 - $1.24 Million
445,874 Added 36.38%
1,671,558 $2.84 Million
Q4 2020

Feb 12, 2021
SELL
$1.18 - $1.98 $118,967 - $199,623
-100,820 Reduced 7.6%
1,225,684 $1.52 Million
Q3 2020

Nov 13, 2020
BUY
$1.01 - $1.81 $75,140 - $134,658
74,397 Added 5.94%
1,326,504 $1.88 Million
Q2 2020

Aug 13, 2020
BUY
$1.03 - $1.69 $101,675 - $166,826
98,714 Added 8.56%
1,252,107 $1.52 Million
Q1 2020

May 14, 2020
BUY
$0.76 - $2.07 $47,658 - $129,807
62,709 Added 5.75%
1,153,393 $1.36 Million
Q4 2019

Feb 13, 2020
BUY
$1.66 - $2.4 $142,904 - $206,608
86,087 Added 8.57%
1,090,684 $2.3 Million
Q3 2019

Nov 12, 2019
BUY
$2.1 - $2.87 $30,561 - $41,767
14,553 Added 1.47%
1,004,597 $2.21 Million
Q2 2019

Aug 14, 2019
BUY
$2.1 - $3.93 $775,922 - $1.45 Million
369,487 Added 59.54%
990,044 $2.5 Million
Q1 2019

May 14, 2019
BUY
$2.35 - $3.83 $334,188 - $544,656
142,208 Added 29.73%
620,557 $2.16 Million
Q4 2018

Feb 13, 2019
BUY
$2.13 - $4.8 $281,696 - $634,809
132,252 Added 38.21%
478,349 $1.1 Million
Q3 2018

Nov 13, 2018
BUY
$2.6 - $4.6 $249,839 - $442,023
96,092 Added 38.44%
346,097 $1.33 Million
Q2 2018

Aug 14, 2018
BUY
$2.13 - $4.2 $72,784 - $143,518
34,171 Added 15.83%
250,005 $843,000
Q3 2017

Nov 14, 2017
BUY
$2.9 - $4.6 $117,658 - $186,631
40,572 Added 23.15%
215,834 $992,000
Q2 2017

Aug 14, 2017
BUY
N/A
175,262
175,262 $376,000

About ACELRX PHARMACEUTICALS INC

ACRX Quotes by TradingView
  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email